Your browser doesn't support javascript.
loading
Immunotherapy for esophageal squamous cell carcinoma: a review.
Mimura, Kosaku; Yamada, Leo; Ujiie, Daisuke; Hayase, Suguru; Tada, Takeshi; Hanayama, Hiroyuki; Thar Min, Aung Kyi; Shibata, Masahiko; Momma, Tomoyuki; Saze, Zenichiro; Ohki, Shinji; Kono, Koji.
Afiliação
  • Mimura K; Department of Gastrointestinal Tract Surgery, Fukushima Medical University.
  • Yamada L; Department of Advanced Cancer Immunotherapy, Fukushima Medical University.
  • Ujiie D; Department of Progressive DOHaD Research, Fukushima Medical University.
  • Hayase S; Department of Gastrointestinal Tract Surgery, Fukushima Medical University.
  • Tada T; Department of Gastrointestinal Tract Surgery, Fukushima Medical University.
  • Hanayama H; Department of Gastrointestinal Tract Surgery, Fukushima Medical University.
  • Thar Min AK; Department of Gastrointestinal Tract Surgery, Fukushima Medical University.
  • Shibata M; Department of Gastrointestinal Tract Surgery, Fukushima Medical University.
  • Momma T; Department of Gastrointestinal Tract Surgery, Fukushima Medical University.
  • Saze Z; Department of Gastrointestinal Tract Surgery, Fukushima Medical University.
  • Ohki S; Department of Advanced Cancer Immunotherapy, Fukushima Medical University.
  • Kono K; Department of Gastrointestinal Tract Surgery, Fukushima Medical University.
Fukushima J Med Sci ; 64(2): 46-53, 2018 Aug 29.
Article em En | MEDLINE | ID: mdl-30058598

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Vacinas Anticâncer / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Carcinoma de Células Escamosas do Esôfago / Imunoterapia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Fukushima J Med Sci Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Vacinas Anticâncer / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Carcinoma de Células Escamosas do Esôfago / Imunoterapia Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Fukushima J Med Sci Ano de publicação: 2018 Tipo de documento: Article